Display options
Share it on

Gastrointest Tumors. 2014 Jun;1(2):53-75. doi: 10.1159/000362585. Epub 2014 May 09.

Consensus on the Prevention, Screening, Early Diagnosis and Treatment of Colorectal Tumors in China: Chinese Society of Gastroenterology, October 14-15, 2011, Shanghai, China.

Gastrointestinal tumors

Jing-Yuan Fang, Shu Zheng, Bo Jiang, Mao-De Lai, Dian-Chun Fang, Ying Han, Qian-Jiu Sheng, Jing-Nan Li, Ying-Xuan Chen, Qin-Yan Gao

Affiliations

  1. Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ; Shanghai Institute of Digestive Disease, Shanghai, China ; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai, China ; State Key Laboratory of Oncogene and Related Genes, Shanghai Jiaotong University, Shanghai, China.
  2. Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences of Zhejiang Province, Cancer Institute, Hangzhou, China ; Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  3. Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  4. Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China.
  5. Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  6. Department of Gastroenterology, General Hospital of Beijing Military Area, Beijing, China.
  7. Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

PMID: 26672726 PMCID: PMC4645581 DOI: 10.1159/000362585

Abstract

BACKGROUND: Colorectal cancer (CRC) is steadily increasing in China. Colorectal adenoma (CRA) is the most important precancerous disease of CRC. Screening for colorectal tumors can aid early diagnosis. Advances in endoscopic mucosal resection and endoscopic submucosal dissection can aid the early treatment of colorectal tumors. Furthermore, because of high risk of recurrence after removal of adenomas under endoscopy, factors contributing to recurrence, the follow-up mode and the interval established, and the feasibility of application and the time of various chemical preventions should be concerned. However, a relevant consensus on the screening, early diagnosis and treatment, and prevention of colorectal tumors in China is lacking.

SUMMARY: The consensus recommendations include epidemiology, pathology, screening, early diagnosis, endoscopic treatment, monitoring and follow-up, and chemoprevention of colorectal tumors in China.

KEY MESSAGE: This is the first consensus on the prevention, screening, early diagnosis and treatment of CRA and CRC in China based on evidence in the literature and on local data.

PRACTICAL IMPLICATIONS: Through reviewing the literature, regional data and passing the consensus by an anonymous vote, gastroenterology experts from all over China launch the consensus recommendations in Shanghai. The incidence and mortality of CRC in China has increased, and the incidence or detection rate of CRA has increased rapidly. Screening for colorectal tumors should be performed at age 50-74 years. Preliminary screening should be undertaken to find persons at high risk, followed by colonoscopy. A screening cycle of 3 years is recommended for persistent interventions. Opportunistic screening is a mode suitable for the current healthcare system and national situation. Colonoscopy combined with pathological examination is the standard method for the diagnosis of colorectal tumors. CRA removal under endoscopy can prevent CRC to some extent, but CRA has an obvious recurrence trend. The follow-up interval after the removal or surgery of colorectal tumors should be different with lesions. Primary prevention of CRA includes improved diet with more fiber, supplements containing calcium and vitamin D, supplements containing folic acid for those with low hemoglobin levels, and cessation of tobacco smoking. Non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors have been recognized to prevent recurrence after adenoma removal.

Keywords: Colorectal tumors; Early diagnosis; Prevention; Screening; Treatment

References

  1. J Gastroenterol. 2008;43(9):641-51 - PubMed
  2. Gastroenterology. 2006 May;130(6):1872-85 - PubMed
  3. Gut. 2001 Apr;48(4):526-35 - PubMed
  4. Gastrointest Endosc. 2005 Mar;61(3):378-84 - PubMed
  5. Gastroenterology. 2004 Sep;127(3):706-13 - PubMed
  6. Radiology. 2011 May;259(2):393-405 - PubMed
  7. J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70 - PubMed
  8. Front Med China. 2010 Dec;4(4):436-42 - PubMed
  9. Inflamm Bowel Dis. 2003 Mar;9(2):116-21 - PubMed
  10. Gut. 2001 Jun;48(6):753-4 - PubMed
  11. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1513-8 - PubMed
  12. Dig Endosc. 2011 May;23 Suppl 1:112-5 - PubMed
  13. Lancet. 2003 May 3;361(9368):1496-501 - PubMed
  14. Gastrointest Endosc. 2011 Sep;74(3):603-9 - PubMed
  15. Ann Intern Med. 2007 Mar 6;146(5):376-89 - PubMed
  16. J Med Screen. 2006;13 Suppl 1:S14-9 - PubMed
  17. Am J Surg Pathol. 2009 Sep;33(9):1287-92 - PubMed
  18. Gut. 2011 Sep;60(9):1236-41 - PubMed
  19. BMJ. 1992 Feb 22;304(6825):483-6 - PubMed
  20. Cell Res. 2004 Jun;14(3):217-26 - PubMed
  21. Gastroenterology. 2006 Apr;130(4):1030-8 - PubMed
  22. Dig Dis Sci. 2010 May;55(5):1221-9 - PubMed
  23. Crit Rev Oncog. 1996;7(5-6):293-342 - PubMed
  24. Gastrointest Endosc. 2001 Jul;54(1):62-6 - PubMed
  25. JAMA. 2003 Dec 10;290(22):2959-67 - PubMed
  26. Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43 - PubMed
  27. Clin Gastroenterol Hepatol. 2006 Mar;4(3):335-42 - PubMed
  28. Cancer. 1996 Apr 15;77(8 Suppl):1707-10 - PubMed
  29. Dig Dis Sci. 2000 May;45(5):976-81 - PubMed
  30. Aliment Pharmacol Ther. 2007 Feb 15;25(4):373-84 - PubMed
  31. Dig Endosc. 2011 May;23 Suppl 1:106-11 - PubMed
  32. Gastroenterology. 2006 Dec;131(6):1700-5 - PubMed
  33. Scand J Gastroenterol. 2009;44(1):46-55 - PubMed
  34. Lancet Oncol. 2007 May;8(5):439-43 - PubMed
  35. Lancet. 2003 May 3;361(9368):1491-5 - PubMed
  36. JAMA. 2007 Jun 6;297(21):2351-9 - PubMed
  37. Zhonghua Yi Xue Za Zhi. 2003 Feb 25;83(4):294-7 - PubMed
  38. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):369-82 - PubMed
  39. Scand J Gastroenterol. 2009;44(5):605-14 - PubMed
  40. Clin Colorectal Cancer. 2010 Apr;9(2):75-6 - PubMed
  41. Gut. 2010 May;59(5):666-89 - PubMed
  42. Gut. 1995 Jan;36(1):81-6 - PubMed
  43. N Engl J Med. 2008 Sep 18;359(12):1218-24 - PubMed
  44. Inflamm Bowel Dis. 2011 Aug;17(8):1800-13 - PubMed
  45. Inflamm Bowel Dis. 2009 Apr;15(4):630-8 - PubMed
  46. Inflamm Bowel Dis. 2010 Nov;16(11):1978-83 - PubMed
  47. Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):289-91 - PubMed
  48. Zhonghua Nei Ke Za Zhi. 2008 Sep;47(9):725-6 - PubMed
  49. J Clin Oncol. 2008 Jul 1;26(19):3222-8 - PubMed
  50. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):281-7 - PubMed
  51. Gastroenterology. 2008 Jan;134(1):21-8 - PubMed
  52. Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:56-63 - PubMed
  53. Med Clin North Am. 2002 Nov;86(6):1217-52 - PubMed
  54. Gastroenterology. 2008 Jan;134(1):29-38 - PubMed
  55. Digestion. 2007;76(1):68-76 - PubMed
  56. N Engl J Med. 2006 Aug 31;355(9):885-95 - PubMed
  57. Endoscopy. 2006 Jun;38(6):613-6 - PubMed
  58. N Engl J Med. 2001 Aug 23;345(8):555-60 - PubMed
  59. N Engl J Med. 1993 Dec 30;329(27):1977-81 - PubMed
  60. N Engl J Med. 1996 Jan 18;334(3):155-9 - PubMed
  61. Am J Gastroenterol. 2008 Nov;103(11):2700-6 - PubMed
  62. Gastroenterology. 2011 Jul;141(1):98-105, 105.e1 - PubMed
  63. Nutr Res Rev. 2008 Jun;21(1):56-67 - PubMed
  64. Int J Colorectal Dis. 2009 Dec;24(12):1441-50 - PubMed
  65. Gastroenterology. 2005 May;128(6):1696-716 - PubMed
  66. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1578-83 - PubMed
  67. Gastroenterology. 2008 May;134(5):1570-95 - PubMed
  68. Aliment Pharmacol Ther. 2006 Sep 15;24(6):965-71 - PubMed
  69. Gastroenterology. 2010 Nov;139(5):1511-8 - PubMed
  70. N Engl J Med. 2006 Aug 31;355(9):873-84 - PubMed
  71. Zhonghua Nei Ke Za Zhi. 2009 Feb;48(2):93-4 - PubMed
  72. J Natl Cancer Inst. 2003 Dec 3;95(23):1765-71 - PubMed
  73. Gastroenterology. 2008 May;134(5):1311-5 - PubMed
  74. N Engl J Med. 2010 May 13;362(19):1795-803 - PubMed
  75. Gastroenterology. 2001 Apr;120(5):1077-83 - PubMed
  76. N Engl J Med. 2000 Apr 20;342(16):1156-62 - PubMed
  77. Zhonghua Zhong Liu Za Zhi. 1993 Jan;15(1):37-40 - PubMed
  78. Dig Endosc. 2011 Apr;23(2):118-23 - PubMed
  79. Carcinogenesis. 2004 Jan;25(1):69-76 - PubMed
  80. N Engl J Med. 2000 Apr 20;342(16):1149-55 - PubMed
  81. Gastroenterology. 2009 Mar;136(3):832-41 - PubMed
  82. Endoscopy. 2008 Apr;40(4):284-90 - PubMed
  83. Fed Proc. 1976 May 1;35(6):1332-8 - PubMed
  84. Science. 1992 Apr 3;256(5053):102-5 - PubMed
  85. PLoS One. 2011;6(8):e22566 - PubMed
  86. Colorectal Dis. 2004 Jul;6(4):236-42 - PubMed
  87. Med J Aust. 2003 Jan 20;178(2):92-3 - PubMed
  88. N Engl J Med. 2000 Jul 20;343(3):162-8 - PubMed
  89. J Dig Dis. 2011 Oct;12(5):371-8 - PubMed
  90. Med Oncol. 2010 Sep;27(3):915-8 - PubMed
  91. Lancet Oncol. 2005 Nov;6(11):871-6 - PubMed
  92. Dis Colon Rectum. 2003 Aug;46(8):1054-9 - PubMed
  93. Dig Liver Dis. 2010 Jan;42(1):45-50 - PubMed
  94. Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2061-3 - PubMed
  95. J Natl Compr Canc Netw. 2009 Sep;7(8):778-831 - PubMed
  96. Carcinogenesis. 2008 Jul;29(7):1415-20 - PubMed
  97. Gastrointest Endosc. 2003 Jul;58(1):76-9 - PubMed
  98. Zhonghua Liu Xing Bing Xue Za Zhi. 2005 May;26(5):366-9 - PubMed
  99. Colorectal Dis. 2011 Nov;13(11):1230-5 - PubMed
  100. Clin Gastroenterol Hepatol. 2010 Feb;8(2):174-82 - PubMed
  101. Ann Intern Med. 2007 Mar 6;146(5):365-75 - PubMed
  102. Gastroenterology. 2010 Feb;138(2):487-92 - PubMed
  103. Gastrointest Endosc. 1998 Oct;48(4):362-70 - PubMed
  104. J Clin Gastroenterol. 2004 Oct;38(9):767-71 - PubMed
  105. N Engl J Med. 2002 Jan 31;346(5):311-20 - PubMed
  106. Can J Gastroenterol. 2010 Aug;24(8):479-80 - PubMed
  107. Gastrointest Endosc. 2009 Mar;69(3 Pt 2):631-6 - PubMed
  108. Epigenetics. 2008 Nov;3(6):330-5 - PubMed
  109. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2182-5 - PubMed
  110. Cancer Prev Res (Phila). 2009 Jun;2(6):581-9 - PubMed
  111. Am J Clin Nutr. 2011 Apr;93(4):817-25 - PubMed
  112. Gastroenterology. 2006 Dec;131(6):1674-82 - PubMed
  113. Am J Gastroenterol. 2006 Feb;101(2):255-62 - PubMed
  114. J Nutr. 2008 Dec;138(12):2372-8 - PubMed
  115. Gut. 2008 Aug;57(8):1166-76 - PubMed
  116. World J Gastroenterol. 2009 Dec 28;15(48):6111-6 - PubMed
  117. Int J Clin Oncol. 2006 Feb;11(1):1-8 - PubMed
  118. Endoscopy. 2010 Oct;42(10):827-33 - PubMed
  119. Ann Intern Med. 2008 Nov 4;149(9):627-37 - PubMed
  120. World J Gastroenterol. 2002 Jun;8(3):488-92 - PubMed
  121. Gastrointest Endosc. 2005 Mar;61(3):385-91 - PubMed
  122. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2800-7 - PubMed
  123. Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1369-71 - PubMed
  124. BMC Cancer. 2009 Sep 18;9:332 - PubMed
  125. Int J Cancer. 1996 May 3;66(3):332-6 - PubMed
  126. JAMA. 2005 Jul 6;294(1):47-55 - PubMed
  127. Gut. 2010 Dec;59(12):1670-9 - PubMed

Publication Types